U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07444086) titled 'QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia' on Feb. 23.
Brief Summary: This Phase III clinical trial aims to assess the efficacy and safety of QLC7401 monotherapy in adults with non-familial primary hypercholesterolemia or mixed dyslipidemia who are not receiving lipid-lowering therapy. Participants will be randomly assigned to receive subcutaneous injections of either QLC7401 or a placebo according to the study schedule.
Study Start Date: March 05
Study Type: INTERVENTIONAL
Condition:
Primary Hypercholesterolemia or Mixed Hyperlipidemia
Intervention:
DRUG: QLC7401
QLC7401 Injection
DRUG: ...